Wolters Kluwer acquires U.S. AI-enabled drug diversion detection software
07 juin 2023 12h07 HE
|
Wolters Kluwer N.V.
Wolters Kluwer acquires U.S. AI-enabled drug diversion detection software Technology leader seeks to help tackle growing drug diversion challenge in the U.S. Waltham, MA – June 7, 2023 – Wolters...
New Report Finds Travel Nurses at the Center of an Alarming Drug Diversion Trend
28 juin 2022 09h00 HE
|
Protenus
BALTIMORE, June 28, 2022 (GLOBE NEWSWIRE) -- Protenus, the leading healthcare compliance analytics platform empowering healthcare to eliminate risk, announced a special mid-year report that details...
Protenus is Top-Performing Solution in KLAS Drug Diversion Monitoring 2022 Report
24 juin 2022 10h00 HE
|
Protenus
BALTIMORE, June 24, 2022 (GLOBE NEWSWIRE) -- Protenus, the leading healthcare compliance analytics platform empowering healthcare to eliminate risk, received the highest overall performance score...
Stop e-Prescribing Bill, Says President of the Association of American Physicians and Surgeons
04 janv. 2018 14h08 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Forcing doctors to electronically prescribe all controlled drugs, as in Oklahoma proposed bill Req. No. 8141, is a “flawed and misguided” idea that...
![rcohen](http://www.globenewswire.com/fr/Attachment/LogoDisplay/397337?filename=397337.gif&size=2)
Robert A. Cohen Joins Appriss as President of Healthcare Division
16 juin 2016 10h54 HE
|
Appriss
LOUISVILLE, Ky., June 16, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, recently announced that Robert A....
![Apriss logo](/news-release/logo/435609/0/435609.jpg?lastModified=03%2F13%2F2017%2015%3A42%3A21&size=2)
President Obama to Address Fifth Annual National Rx Drug Abuse & Heroin Summit; Appriss to Sponsor and Host Speaking Session
24 mars 2016 12h44 HE
|
Appriss
LOUISVILLE, K.Y., March 24, 2016 (GLOBE NEWSWIRE) -- Appriss, Inc., will sponsor the 2016 National Rx Drug Abuse & Heroin Summit, which runs from March 28 through March 31 at The Westin Peachtree...
![Apriss logo](/news-release/logo/435609/0/435609.jpg?lastModified=03%2F13%2F2017%2015%3A42%3A21&size=2)
Marshfield Clinic First in Wisconsin to Integrate Prescription Monitoring Data into Clinical Workflow
02 mars 2016 11h08 HE
|
Appriss
LOUISVILLE, KY., March 2, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that is has signed an...
![Apriss logo](/news-release/logo/435609/0/435609.jpg?lastModified=03%2F13%2F2017%2015%3A42%3A21&size=2)
Appriss Awarded Texas State Board of Pharmacy Contract for New Prescription Monitoring Solution
22 févr. 2016 10h32 HE
|
Appriss
LOUISVILLE, Ky., Feb. 22, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the Texas State Board...
![Apriss logo](/news-release/logo/435609/0/435609.jpg?lastModified=03%2F13%2F2017%2015%3A42%3A21&size=2)
Massachusetts Selects Appriss' PMP Solutions to Enhance Interoperability
01 févr. 2016 12h09 HE
|
Appriss
LOUISVILLE, Ky., Feb. 1, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety, retail and healthcare, announced that it has signed an...
![Apriss logo](/news-release/logo/435609/0/435609.jpg?lastModified=03%2F13%2F2017%2015%3A42%3A21&size=2)
Vermont Adopts Appriss' Platform to Mitigate Drug Diversion
11 janv. 2016 11h05 HE
|
Appriss
LOUISVILLE, Ky., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of Vermont...